Get the Stockscreener App
24.09
1.55%
-0.38
Moderna Inc stock is traded at $24.09, with a volume of 8.26M.
It is down -1.55% in the last 24 hours and down -26.24% over the past month.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
See More
Previous Close:
$24.47
Open:
$24.25
24h Volume:
8.26M
Relative Volume:
0.88
Market Cap:
$9.37B
Revenue:
$3.14B
Net Income/Loss:
$-3.36B
P/E Ratio:
-2.7595
EPS:
-8.73
Net Cash Flow:
$-4.03B
1W Performance:
-11.17%
1M Performance:
-26.24%
6M Performance:
-22.52%
1Y Performance:
-68.95%
1-Day Range:
$23.84
$24.38
1-Week Range:
$23.84
$27.22
52-Week Range:
$23.15
$79.96
Moderna Inc Stock (MRNA) Company Profile
Name
Moderna Inc
Sector
Industry
Phone
(617) 714-6500
Address
325 BINNEY STREET, CAMBRIDGE
Compare MRNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
24.09 | 9.52B | 3.14B | -3.36B | -4.03B | -8.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-13-25 | Initiated | Citigroup | Neutral |
| Feb-18-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-29-25 | Downgrade | Goldman | Buy → Neutral |
| Dec-18-24 | Downgrade | Argus | Buy → Hold |
| Dec-10-24 | Resumed | BofA Securities | Underperform |
| Nov-19-24 | Initiated | Berenberg | Hold |
| Nov-18-24 | Upgrade | HSBC Securities | Hold → Buy |
| Nov-15-24 | Initiated | Wolfe Research | Underperform |
| Oct-17-24 | Initiated | Bernstein | Mkt Perform |
| Sep-13-24 | Downgrade | JP Morgan | Neutral → Underweight |
| Sep-13-24 | Downgrade | Jefferies | Buy → Hold |
| Sep-13-24 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-28-24 | Upgrade | HSBC Securities | Reduce → Hold |
| Aug-07-24 | Upgrade | Deutsche Bank | Sell → Hold |
| Aug-05-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-26-24 | Downgrade | HSBC Securities | Hold → Reduce |
| Jan-02-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Nov-29-23 | Initiated | Canaccord Genuity | Hold |
| Nov-03-23 | Upgrade | HSBC Securities | Reduce → Hold |
| Nov-02-23 | Downgrade | Deutsche Bank | Hold → Sell |
| Aug-04-23 | Downgrade | TD Cowen | Outperform → Market Perform |
| Aug-03-23 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-24-23 | Initiated | William Blair | Mkt Perform |
| Jul-14-23 | Initiated | HSBC Securities | Reduce |
| Jun-26-23 | Upgrade | UBS | Neutral → Buy |
| Apr-26-23 | Initiated | Guggenheim | Neutral |
| Mar-13-23 | Upgrade | TD Cowen | Market Perform → Outperform |
| Mar-02-23 | Initiated | RBC Capital Mkts | Outperform |
| Feb-24-23 | Downgrade | SVB Securities | Market Perform → Underperform |
| Dec-19-22 | Upgrade | Jefferies | Hold → Buy |
| Dec-14-22 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Oct-21-22 | Upgrade | SVB Leerink | Underperform → Mkt Perform |
| Sep-08-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-01-22 | Upgrade | Redburn | Sell → Neutral |
| Jan-26-22 | Upgrade | Deutsche Bank | Sell → Hold |
| Jan-21-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Jan-21-22 | Initiated | UBS | Neutral |
| Dec-07-21 | Initiated | Cowen | Market Perform |
| Nov-09-21 | Initiated | Wolfe Research | Outperform |
| Oct-22-21 | Initiated | Deutsche Bank | Sell |
| Oct-15-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-06-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Aug-06-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jul-15-21 | Reiterated | Jefferies | Hold |
| Feb-01-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Dec-16-20 | Downgrade | Jefferies | Buy → Hold |
| Dec-16-20 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-09-20 | Downgrade | Needham | Buy → Hold |
| Nov-23-20 | Initiated | Wells Fargo | Equal Weight |
| Nov-17-20 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-08-20 | Downgrade | SVB Leerink | Mkt Perform → Underperform |
| Jul-23-20 | Initiated | SVB Leerink | Mkt Perform |
| Jul-20-20 | Downgrade | JP Morgan | Overweight → Neutral |
| Jul-13-20 | Initiated | Jefferies | Buy |
| Jun-30-20 | Initiated | Argus | Buy |
| Jun-08-20 | Initiated | Barclays | Overweight |
| Apr-30-20 | Initiated | BMO Capital Markets | Outperform |
| Mar-05-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Dec-03-19 | Resumed | BofA/Merrill | Buy |
| Oct-25-19 | Initiated | ROTH Capital | Buy |
| Apr-05-19 | Initiated | Chardan Capital Markets | Buy |
View All
Moderna Inc Stock (MRNA) Latest News
Moderna, Inc. $MRNA Shares Bought by FORA Capital LLC - MarketBeat
Moderna Inc. stock daily chart insightsPortfolio Risk Summary & Real-Time Chart Pattern Alerts - Newser
Aristides Capital LLC Acquires Shares of 20,000 Moderna, Inc. $MRNA - MarketBeat
Earnings visualization tools for Moderna Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
Has Moderna Inc. formed a bullish divergenceJuly 2025 Breakouts & AI Driven Stock Price Forecasts - Newser
Volume spikes in Moderna Inc. stock – what they meanMarket Growth Summary & Weekly Top Gainers Trade List - Newser
What moving averages say about Moderna Inc.Trade Volume Report & Weekly High Potential Stock Alerts - Newser
Moderna (NASDAQ:MRNA) Trading Down 5.2% After Analyst Downgrade - MarketBeat
Moderna, Inc. $MRNA Shares Sold by Groupe la Francaise - MarketBeat
What data driven models say about Moderna Inc.’s future2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser
Comparing Moderna Inc. in custom built stock radarsJuly 2025 PreEarnings & Capital Efficient Trading Techniques - Newser
Northern Trust Corp Boosts Stock Holdings in Moderna, Inc. $MRNA - MarketBeat
Published on: 2025-08-30 23:53:49 - Newser
Using flow based indicators on Moderna Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - Newser
Detecting support and resistance levels for Moderna Inc.July 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
CDC sets return date for all employees after Aug. 8 shooting - Seeking Alpha
Stock Analysis | Moderna OutlookTechnical Downturn and Mixed Analyst Signals - AInvest
When is the best time to exit Moderna Inc.2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Moderna Inc. stock retracement – recovery analysisTrade Exit Report & Consistent Profit Alerts - Newser
Hsbc Holdings PLC Sells 65,993 Shares of Moderna, Inc. $MRNA - MarketBeat
Cresset Asset Management LLC Acquires Shares of 18,420 Moderna, Inc. $MRNA - MarketBeat
Can Moderna Inc. rally from current levelsTake Profit & Real-Time Chart Breakout Alerts - Newser
Moderna Inc Stock (MRNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.96%
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):